While many platforms stay in discovery mode for years, Electrome was designed from the start with translation in mind. Our first therapy—for pain and inflammation—is ready for market with a regulatory path via FDA 510(k) clearance, grounded in substantial equivalence to cleared devices like SofPulse® and ActiPatch®.
Their device isn't the ActiPatch or SofPulse then. And it's ready for market?
We are positioned to generate revenue in year one
I'm wondering if Mayer already sent the Shenzhen CICD device through FDA 510(k) clearance as I hypothesized. Or maybe he's about to -- should take 90 days.
Any BIELiever who lives near Boston should ABSOLUTELY attend this launch. And take pictures. I wish I were closer. This is BIG.
Kelly can attend! She'll be done in court before noon.